Related Experiment Video
Updated: Jun 8, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome
Yuen-Yee Cheng1, David Chau, Thomas Chan
1Division of Haematology and Medical Oncology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.
Abstract:
Npm1(+/-) heterozygous mice develop a haematological disorder with features resembling human myelodysplastic syndrome (MDS). Promoter hypermethylation of the NPM1 gene may lead to suppressed gene transcription and hence functional haploinsufficiency, which contributes to the development of MDS. Thirty-one patients with MDS and eight normal individuals were studied for promoter methylation and mRNA expression of NPM1. Methylation-specific PCR (MSP), COBRA and bisulfite sequencing were used to examine the NPM1 methylation status. Quantitative PCR was used to assess the expression of NPM1. NPM1 DNA methylation was rare, occurring in one of 31 cases as determined by MSP. There was no significant difference in NPM1 mRNA expression between MDS and normal blood samples. In conclusion, the finding suggests that NPM1 methylation is rare in MDS and does not play a major role in its pathogenesis.
Insights
Promoter hypermethylation of the NPM1 gene may contribute to myelodysplastic syndrome (MDS). This study found NPM1 gene methylation is rare in MDS patients, suggesting it does not play a major role in the disease.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Myelodysplastic syndrome (MDS) is a group of bone marrow failure disorders.
- Npm1(+/-) heterozygous mice exhibit MDS-like features.
- NPM1 gene promoter hypermethylation is a potential mechanism for MDS pathogenesis.
Purpose of the Study:
- To investigate the role of NPM1 gene promoter methylation and mRNA expression in human MDS.
- To determine if NPM1 methylation is a significant factor in MDS development.
Main Methods:
- Studied 31 MDS patients and 8 normal individuals.
- Utilized methylation-specific PCR (MSP), COBRA, and bisulfite sequencing for NPM1 methylation analysis.
- Employed quantitative PCR to measure NPM1 mRNA expression.
Main Results:
- NPM1 DNA methylation was detected in only one of 31 MDS cases.
- No significant difference in NPM1 mRNA expression was observed between MDS patients and normal individuals.
- NPM1 methylation appears to be a rare event in MDS.
Conclusions:
- NPM1 gene promoter methylation is infrequent in human MDS.
- NPM1 methylation does not appear to be a major driver in the pathogenesis of MDS.
- Further research may be needed to explore other mechanisms contributing to MDS.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
13:47Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...